A Breakthrough Plastic That Leaves Zero Microplastics Behind Is Here

In reworking the connections within plastic materials, researchers are studying how plant-based compounds could eventually ...
Yahoo Finance

Statement on new EU choline chloride anti-dumping measures

MONTVALE, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- As producers of choline chloride in the EU, Eastman and Balchem welcome the European Union's decision published on December 19, 2025 to adopt ...
Monthly Prescribing Reference

Intravenous Choline Chloride Fast-Tracked for Intestinal Failure-Associated Liver Disease

The FDA has granted Fast Track designation to intravenous choline chloride (Protara Therapeutics), an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure ...
Business Insider

Protara Therapeutics Announces Dosing of First Patient in Phase 3 Registrational THRIVE-3 Trial of IV Choline Chloride in Patients on Long-Term Parenteral Support

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...

Choline Chloride Market Size to Cross $1 Billion by 2032: Analysis of Form Types, Application Segments, Purity Grades, Production Technologies, Distribution Channels, Regional ...

Focus on production innovation, evolving regulations, and growing demand in animal feed and human nutrition to capture market opportunities in the choline chloride sector Choline Chloride Market ...
Nasdaq

Protara Reaches Alignment With FDA On A Registrational Path Forward For IV Choline Chloride

(RTTNews) - Protara Therapeutics, Inc. (TARA) announced Friday that it has reached alignment with the U.S. Food and Drug Administration (FDA) on a registrational path forward for intravenous (IV) ...
Nasdaq

Protara Therapeutics Receives Fast Track Designation from U.S. FDA for Intravenous Choline Chloride for the Treatment of Intestinal Failure Associated Liver Disease

NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing treatments for rare and specialty diseases with significant unmet needs, today ...
Business Wire

ArTara Therapeutics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on Choline Chloride for Injection for Intestinal Failure Associated Liver Disease (IFALD)

NEW YORK--(BUSINESS WIRE)--ArTara Therapeutics, a clinical-stage company developing treatments for rare diseases with significant unmet needs, today announced that it has successfully completed an End ...
Mena FN

Statement On New EU Choline Chloride Anti-Dumping Measures

(MENAFN- GlobeNewsWire - Nasdaq) EU producers laud EU for addressing choline chloride dumping by China; measures will help preserve jobs and secure feed supply chain MONTVALE, N.J., Dec. 22, 2025 ...